CLOV vs TENX · rev $1.37B vs P/E 3.4, $24.1M cap
Clover Health Investments Corp (CLOV) versus Tenax Therapeutics Inc (TENX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Tenax Therapeutics Inc (TENX) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported TENX revenue for 2025-09-30 was $0. Net income was -$37.1M. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
CLOV currently screens at market cap $1.55B. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
Not investment advice. Open the CLOV and TENX stock pages for the full models.
Not investment advice.